The vaccine campaign began on December 27, 2020 in France, following the authorization of the European Medicines Agency for vaccines from Pfizer-BioNTech and Wednesday from Moderna.
Yet almost two weeks later, the number of vaccinations remains paltry: barely a few thousand. This is an unacceptable situation, when we know that nearly 500,000 vaccines are delivered every week.
In addition, the opaque logistics of the vaccine do not seem to be paying off for the time being. Thus, the vaccine should be distributed more widely and more quickly to those who need it and to those who wish to be vaccinated. Why not entrust the departments, which are more efficient at the local level, to manage it?
In addition, once a drug receives marketing authorization – as is the case with Pfizer-BioNTech’s vaccine – it should be available. This is not the case today. Therefore, it is necessary to increase the number of vaccines, its availability for the French, and especially the number of vaccinations performed each day.
Finally, if patient consent is essential, the document distributed today is too long, too complex and the time between consent and vaccination unnecessarily lengthens the procedures: faced with the epidemic, it is necessary to show pragmatism and speed.
French people wishing to be vaccinated must be able to have access to the vaccine.